Dr. Andrew Weil on the Joe Rogan Experience #1213, fact-checked

What the evidence shows: Dr. John Sarno's tension myositis syndrome (TMS) theory holds that chronic back pain is generated by repressed emotion rather than structural spinal pathology, and that patients can be cured by accepting this psychological explanation. Sarno never published controlled clinical trials of his diagnosis or claimed cure rates, and TMS as he formulated it is not recognized in mainstream spine medicine or psychiatric diagnostic manuals. A related but distinct approach, Pain Reprocessing Therapy, was tested in a 2021 randomized controlled trial (151 adults with chronic back pain) published in JAMA Psychiatry: 66% of the treatment group were pain-free or nearly pain-free after treatment, versus 20% for placebo and 10% for usual care, with effects largely maintained at one year; this supports a role for psychological/brain-based mechanisms in some chronic back pain but does not validate Sarno's specific repressed-emotion mechanism or his claims about herniated discs. Separately, NIH-indexed clinical literature documents that herniated discs are frequently asymptomatic on imaging and that over 85% of acute symptomatic herniations resolve within 8 to 12 weeks with conservative (non-surgical) management alone, meaning a friend's pain resolving after reading a book, without surgery, is consistent with the disc's natural history and does not by itself demonstrate a psychosomatic cause. Overall, the mind-body pain literature is genuine and evolving, but the specific TMS mechanism and the causal inference drawn from a single anecdote are not supported by controlled evidence.

What the evidence shows: Weil claimed that removing half the liver allows it to regenerate within 36 hours. The liver does have a well-documented capacity to regenerate after partial removal, and cellular proliferation (DNA synthesis) does begin quickly, with hepatocyte DNA synthesis peaking around postoperative days 7-10 in humans. However, restoration of liver mass and volume is a much slower process: complete liver mass recovery after partial hepatectomy typically takes up to about 3 months, while full functional recovery can extend to 90-180 days. Clinical data on living liver donors similarly show the remnant liver grows back to full size within about two to three months, not within a day and a half. The claim conflates the onset of cellular regenerative activity with completed regeneration of the organ, which the evidence shows takes weeks to months rather than 36 hours.

What the evidence shows: Weil, citing unspecified secondhand information ("the word is"), claims 25% of US women aged 40-50 and 10% of all US adults take antidepressants. CDC/NCHS data show overall adult antidepressant use running higher than 10% in most measured years: 13.6% of adults 20+ in the 2015-2018 NHANES survey and 11.4% of adults 18+ in the 2023 NHIS survey, so Weil's 10% figure understates the most recently measured national rates, though it is in the right range. For women, CDC data confirm markedly higher use than men and than the adult average, rising with age: 17.7% of adult women overall (2015-2018) and nearly one in four women 60 and older, the highest of any group measured, while women overall were at 15.3% and adults 45-64 (both sexes combined) were at 12.1% in 2023. No CDC dataset reviewed reports antidepressant use specifically for women aged 40-50, so the claimed 25% for that narrower band cannot be directly confirmed against an established figure; it is plausible that usage in this range sits somewhere between the mixed-sex 45-64 rate and the women-60-plus rate, but that is inference rather than documented data. Overall, the claim's direction (women, especially in midlife, use antidepressants at markedly higher rates than the general adult population) is well supported, but neither specific number matches an established CDC statistic precisely.

What the evidence shows: A 2014 Johns Hopkins open-label pilot study did find that 12 of 15 nicotine-dependent smokers (80%) showed biologically verified, seven-day point-prevalence abstinence at 6-month follow-up after receiving two to three moderate-to-high doses of psilocybin combined with cognitive behavioral therapy. A 2016 long-term follow-up of the same 15-person cohort found the abstinence rate declined over time: 67% (10 of 15) remained abstinent at 12 months, and 60% (9 of 15) at a mean of 30 months. The study had no control group or placebo condition and a very small sample (n=15), so the 80% figure, while accurately quoted from the original 6-month result, comes from a preliminary open-label pilot that the study authors themselves say cannot support definitive efficacy conclusions; it has not been confirmed in a large randomized controlled trial. The claim is factually consistent with the published pilot data but omits that the sample was tiny, uncontrolled, and that the abstinence rate fell with longer follow-up.

What the evidence shows: The claim references a single historical case report published in 1952 in the British Medical Journal by anesthetist Albert A. Mason, describing a teenage boy diagnosed with congenital ichthyosiform erythrodermia of Brocq, a rare hereditary skin disorder, whose skin cleared substantially (nearly complete clearing on some areas, partial elsewhere) over repeated sessions of hypnotic suggestion applied one body region at a time. Mason published a further account in 1955 discussing his continued clinical experience with the case. In the following years, Mason and other clinicians who attempted the same hypnotic approach with additional ichthyosis patients were unable to reproduce comparable results, and no controlled study has since replicated the original finding. The condition treated was a specific, rare subtype rather than ichthyosis in general, and the improvement was not uniform across the whole body as the claim implies. The episode is best characterized as a single, unreplicated historical case report rather than established evidence that hypnosis cures ichthyosis.

What the evidence shows: Weil claims that no native resident of Lourdes has ever been cured there and that a pilgrim's chance of healing rises with the distance traveled to reach the shrine. A 2012 peer-reviewed history of the Lourdes Medical Bureau's certification process, published in the Journal of the History of Medicine and Allied Sciences, documents that the Catholic Church has recognized 67 cures as medically inexplicable miracles between 1862 and 2005, out of roughly 4,500 cures acknowledged (mostly on weaker pre-WWII evidence) between 1858 and 1976. The article tracks the sex, age, and nationality of certified patients in detail (the 25 cures certified 1947-1976 were three-quarters female, ranged in age from 8 to 52, and were all Western European), but it contains no data breaking down cure rates by whether the patient was a Lourdes resident or by distance traveled to the shrine, and no such analysis appears in the peer-reviewed literature on Lourdes cures more broadly. In the absence of any tracked statistic on residency or travel distance, Weil's specific figures cannot be confirmed or refuted against documented data. The claim functions as long-circulated folklore about Lourdes rather than an established medical or demographic finding, and its status is best described as unverifiable.